According to Frost & Sullivan, Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators
Posted on: Thursday, 5 March 2009, 04:32 CST
(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), European Bone Growth and Spinal Fusion Stimulators Markets, finds that the markets earned revenues of
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the European bone growth and spinal fusion stimulators markets, then send an e-mail to
"An increasing number of scientific research studies support these technologies," notes a Frost & Sullivan analyst. "Each year, manufacturers and independent researchers are publishing more papers, describing in greater detail how stimulation has beneficial effects and which types of patients can best benefit from this treatment."
There is still a great deal of debate among orthopaedicians about what dosage of stimulation is optimal for a given patient with a given condition. However, most of them now agree that the technology is able to produce good results in most selected patients.
Reimbursement still remains an issue for the market, but some hospitals are now including bone growth stimulation in their budgets. Although used primarily for treating worst-case failures, they are gradually gaining acceptance as an alternative to non-union surgery.
"This technology has met with much resistance in
European Bone Growth and Spinal Fusion Stimulators Markets is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: European Markets for Bone Grafts and Bone Cements and Issues and Trends in Infection Control Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit http://www.frost.com.
European Bone Growth and Spinal Fusion Stimulators Markets
M281
Contact: Katja Feick Corporate Communications P: +49 (0) 69 7703343 E: katja.feick@frost.com http://www.frost.comSOURCE Frost & Sullivan
Source: PR Newswire
Related Articles
- Mobile Gaming to Reach $18 Billion by 2014, Fueled by Subscriber Growth in Emerging Markets, Pyramid Research Finds
- This New Report Examines the High-Growth Energy Drinks Market With Recommendations for Courses of Action That Can Benefit Stakeholders
- World Optical Transport and Switching Infrastructure Markets Provides Insights into the Current Trends in the Market and Factors Influencing the Current Growth in the Market
- Rocher Deboule Hires Fuller Fletcher &Amp; Associates for European IR
- Tercica Receives Marketing Approval for Increlex in the European Union
- Verizon Reports Strong 1Q 2007 Results, Driven By Top-Line Growth Across Key Markets
- Proving the Efficacy of Phytonutrients Critical for Growth of the Market
- Cost-Reduction Drives Growth of MSS Markets in Latin America
- Reimbursement Regulations Underline the Need for Innovative Marketing and Product Strategies in the European Enteral Feeds Market
- The Emergence of Wireless Technology Has Allowed and Will Allow Isps to Drive Further Value-Added Growth Within the Market into the Next Few Years - Internet Access: Global Industry Guide
 |
 |
User Comments (0)
RSS Feeds